Open | - |
Close | - |
Volume / Avg. | 0 / 207.200K |
Day Range | - - - |
52 Wk Range | 261.590 - 494.050 |
Market Cap | $9.509B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 51 |
Short Interest | 2.91% |
Days to Cover | 3.6 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Danaher (NYSE:DHR).
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by UBS on Friday, February 16, 2024. The analyst firm set a price target for 420.00 expecting BIO to rise to within 12 months (a possible 25.96% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $333.43 last updated March 18, 2024 at 4:00 PM EDT.
A quarterly cash dividend of $0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on Invalid DateTime.
Bio-Rad Laboratories’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.